Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
1. Iti-007
2. Iti-722
3. Lumateperone
1. 1187020-80-9
2. Lumateperone (tosylate)
3. Iti-007 Tosylate
4. Iti 007
5. Lumateperone Tosylate [usan]
6. Jie88n006o
7. 1-(4-fluorophenyl)-4-[(10r,15s)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one;4-methylbenzenesulfonic Acid
8. Lumateperone Tosylate (usan)
9. Lumateperone(iti-007)
10. Caplyta
11. Chembl3233142
12. Unii-jie88n006o
13. Caplyta (tn)
14. Schembl1769664
15. Iti-007iti-007
16. Dtxsid701026210
17. Lumateperone Tosylate [who-dd]
18. Cs-5540
19. Ac-36919
20. Bl167386
21. Hy-19733
22. Lumateperone Tosylate [orange Book]
23. D11170
24. A858354
25. Q27281520
26. 1-(4-fluoro-phenyl)-4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one Tosylate Salt
27. 1-(4-fluorophenyl)-4-((6br,10as)-3-methyl-2,3,6b,7,10,10a-hexahydro-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(9h)-yl)butan-1-one 4-methylbenzenesulfonate
28. 1-(4-fluorophenyl)-4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalin-8(7h)-yl)butan-1-one 4-methylbenzenesulfonate (1:1)
29. 1-(4-fluorophenyl)-4-[(6br,10as)-2,3,6b,9,10,10a-hexahydro-3-methyl-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7h)-yl]-1-butanone 4-methylbenzenesulfonate
30. 1-butanone, 1-(4-fluorophenyl)-4-((6br,10as)-2,3,6b,9,10,10a-hexahydro-3-methyl-1h-pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalin-8(7h)-yl)-, 4-methylbenzenesulfonate (1:1)
1. Iti-722
2. 313368-91-1
3. Lumateperone
4. 70bsq12069
Molecular Weight | 565.7 g/mol |
---|---|
Molecular Formula | C31H36FN3O4S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 565.24105597 g/mol |
Monoisotopic Mass | 565.24105597 g/mol |
Topological Polar Surface Area | 89.5 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 799 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-09-21
Pay. Date : 2023-08-17
DMF Number : 38206
Submission : 2023-03-31
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-12-30
Written Confirmation Number : WC-0390
Address of the Firm :
NDC Package Code : 71796-058
Start Marketing Date : 2023-03-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-09-05
Pay. Date : 2023-05-17
DMF Number : 38407
Submission : 2023-07-22
Status : Active
Type : II
NDC Package Code : 70966-0039
Start Marketing Date : 2019-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
About the Company : Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Beijing Sjar Technology Development Co., Ltd. founded in 2014, it is a high-tech enterprise which specialized in the research and development of active pharmaceutical ingredients a...
About the Company : Medichem is an indepently-owned company based in Barcelona. Founded in 1972 and with more than 45 years, Medichem has been engaged in the process development and manufacture of Act...
About the Company : Sekhmet Pharmaventures Pvt. Ltd., an Indian subsidiary of Gamot API Pte. Ltd., is backed by prominent private equity firms including PAG, CX Partners, and Samara Capital. The compa...
About the Company : Sichuan Taienkang Pharmaceutical Co., Ltd., established in 2020, is a subsidiary of Guangdong Taienkang Pharmaceutical Co., Ltd. The company specializes in the R&D, production, and...
About the Company : Wuhan Sun-shine chemical Corporation Limited (Shanghai Sun-shine Chemical Technology Corporation Limited) is a high-tech enterprise engaged inR&D and sales of related compounds of ...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Lumateperone Tosylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lumateperone Tosylate manufacturer or Lumateperone Tosylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lumateperone Tosylate manufacturer or Lumateperone Tosylate supplier.
PharmaCompass also assists you with knowing the Lumateperone Tosylate API Price utilized in the formulation of products. Lumateperone Tosylate API Price is not always fixed or binding as the Lumateperone Tosylate Price is obtained through a variety of data sources. The Lumateperone Tosylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lumateperone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lumateperone, including repackagers and relabelers. The FDA regulates Lumateperone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lumateperone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lumateperone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lumateperone supplier is an individual or a company that provides Lumateperone active pharmaceutical ingredient (API) or Lumateperone finished formulations upon request. The Lumateperone suppliers may include Lumateperone API manufacturers, exporters, distributors and traders.
click here to find a list of Lumateperone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lumateperone DMF (Drug Master File) is a document detailing the whole manufacturing process of Lumateperone active pharmaceutical ingredient (API) in detail. Different forms of Lumateperone DMFs exist exist since differing nations have different regulations, such as Lumateperone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lumateperone DMF submitted to regulatory agencies in the US is known as a USDMF. Lumateperone USDMF includes data on Lumateperone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lumateperone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lumateperone suppliers with USDMF on PharmaCompass.
A Lumateperone written confirmation (Lumateperone WC) is an official document issued by a regulatory agency to a Lumateperone manufacturer, verifying that the manufacturing facility of a Lumateperone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lumateperone APIs or Lumateperone finished pharmaceutical products to another nation, regulatory agencies frequently require a Lumateperone WC (written confirmation) as part of the regulatory process.
click here to find a list of Lumateperone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lumateperone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lumateperone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lumateperone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lumateperone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lumateperone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lumateperone suppliers with NDC on PharmaCompass.
Lumateperone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lumateperone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lumateperone GMP manufacturer or Lumateperone GMP API supplier for your needs.
A Lumateperone CoA (Certificate of Analysis) is a formal document that attests to Lumateperone's compliance with Lumateperone specifications and serves as a tool for batch-level quality control.
Lumateperone CoA mostly includes findings from lab analyses of a specific batch. For each Lumateperone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lumateperone may be tested according to a variety of international standards, such as European Pharmacopoeia (Lumateperone EP), Lumateperone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lumateperone USP).